# BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX

Study · id `cardio:ct-nct02623140` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02623140](<https://clinicaltrials.gov/study/NCT02623140>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02623140

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3150 participants.

## Technical summary

Registry record NCT02623140. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-10-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3150 participants (enrolled count; ClinicalTrials.gov record NCT02623140, source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02623140, source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)
- Primary completion: 2018-10-01 (actual) (ClinicalTrials.gov record NCT02623140, source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)
- Completion: 2023-10-01 (actual) (ClinicalTrials.gov record NCT02623140, source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02623140, source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02623140-2026-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
- Acronym: SORT OUT IX
- Condition: Ischaemic Heart Disease
- Intervention (Device): Biofreedom
- Intervention (Device): Orsiro
- Lead sponsor: Odense University Hospital
- Lead sponsor class: OTHER
- Collaborator: Aarhus University Hospital Skejby
- Collaborator class: OTHER
- Collaborator: Aalborg University Hospital
- Collaborator class: OTHER
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Odense University Hospital (`cardio:org-odense-university-hospital`)
- Registry lists this organization as a collaborator: Aarhus University Hospital Skejby (`cardio:org-aarhus-university-hospital-skejby`)
- Registry lists this organization as a collaborator: Aalborg University Hospital (`cardio:org-aalborg-university-hospital`)
- Registry lists this organization as a collaborator: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial (`cardio:pubmed-32434381`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dc2bdd0e9e2d2e4850e9a9c170322a0f833207653c0d78a9d8db3156dc08574b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
